내용 바로 가기

낫적혈구병(Sickle Cell Disease)

혈관폐쇄위기(Vaso-Occlusive Crisis) 및 급성흉부증후군(Acute Chest Syndrome)

통증 관리

What is the best pharmacologic treatment for sickle cell disease pain crises? (새로운 창 열기)

Baker M, Hafner JW.

Source‎: Ann Emerg Med 2012;59(6):515-6.

Indexed‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (새로운 창 열기)

Update on pain management in sickle cell disease. (새로운 창 열기)

Ballas SK.

Source‎: Hemoglobin 2011;35(5-6):520-9.

Indexed‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (새로운 창 열기)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (새로운 창 열기)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Source‎: Thromb Haemost 2007;98(2):392-6.

Indexed‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (새로운 창 열기)

수액 요법(Hydration Therapy; Fluid Management)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (새로운 창 열기)

Okomo U, Meremikwu MM.

Source‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Indexed‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (새로운 창 열기)

산소 보충(Oxygen Supplementation)

Guidelines for the management of the acute painful crisis in sickle cell disease. (새로운 창 열기)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Source‎: Br J Haematol 2003;120(5):744-52.

Indexed‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (새로운 창 열기)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (새로운 창 열기)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Source‎: Diving Hyperb Med 2012;42(2):82-4.

Indexed‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (새로운 창 열기)

항생제 및 호흡기 치료

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (새로운 창 열기)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Source‎: Hemoglobin 2004;28(2):85-102.

Indexed‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (새로운 창 열기)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (새로운 창 열기)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Source‎: N Engl J Med 1995;333(11):699-703.

Indexed‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (새로운 창 열기)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (새로운 창 열기)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Source‎: J Investig Med 2008;56(8):1023-7.

Indexed‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (새로운 창 열기)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (새로운 창 열기)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Source‎: N Engl J Med 2000;342(25):1855-65.

Indexed‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (새로운 창 열기)